Insilico’s co-CEO hopes ‘we might have a chance to stop biological aging’ after promising results from its fibrosis drug trial

Drugmakers hope they can ease Asia's healthcare burden by tackling aging at its source, and one says it now has early evidence it's possible.

This story was originally reported by Fortune. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.